Agile Therapeutics (AGRX) Stock Forecast & Price Target

$1.45

+0.01 (+0.69%)

(As of 07/26/2024 ET)

Agile Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 1 Analyst Ratings

Based on 1 Wall Street analysts who have issued ratings for Agile Therapeutics in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for AGRX.

Consensus Price Target

$5.00
244.83% Upside

High Forecast	$5.00
Average Forecast	$5.00
Low Forecast	$5.00

According to the 1 analysts' twelve-month price targets for Agile Therapeutics, the average price target is $5.00. The highest price target for AGRX is $5.00, while the lowest price target for AGRX is $5.00. The average price target represents a forecasted upside of 244.83% from the current price of $1.45.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Hold	Hold	Moderate Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$5.00	$5.00	$8.50	$12.00
Forecasted Upside	244.83% Upside	189.02% Upside	178.69% Upside	223.45% Upside

Get Agile Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter.

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

AGRX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AGRX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Agile Therapeutics Stock vs. The Competition

Type	Agile Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.72	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	244.83% Upside	3,123.38% Upside	9.16% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
3/18/2024	Maxim Group 5 of 5 stars		Reiterated Rating	Buy ➝ Hold
6/7/2023	HC Wainwright 3 of 5 stars		Reiterated Rating	Buy	$12.00	+223.45%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:11 AM ET.

AGRX Forecast - Frequently Asked Questions

What is Agile Therapeutics' forecast for 2024?: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Agile Therapeutics is $5.00, with a high forecast of $5.00 and a low forecast of $5.00.
Should I buy or sell Agile Therapeutics stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agile Therapeutics in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AGRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AGRX, but not buy additional shares or sell existing shares.
Does Agile Therapeutics's stock price have much upside?: According to analysts, Agile Therapeutics's stock has a predicted upside of 189.02% based on their 12-month stock forecasts.
Do Wall Street analysts like Agile Therapeutics more than its competitors?: Analysts like Agile Therapeutics less than other "medical" companies. The consensus rating for Agile Therapeutics is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AGRX compares to other companies.